First, our study only illustrates the difference between patients with HCC and healthy controls with respect to the S100 family; the molecular mechanisms underlying the relationship between the S100 family and HCC were not investigated, and thus additional studies are required to determine the mechanisms involved. Here, S100A1 is linked to hepatocellular carcinoma.